1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Analysis & Statistics, July 2016 (p10)

Therapy Analysis & Statistics, July 2016 (p10)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

271-300 of about 13 000 reports

Purchase Reports From Reputable Market Research Publishers

Dual Specificity Mitogen Activated Protein Kinase Kinase 2 (ERK Activator Kinase 2 or MAPK/ERK Kinase 2 or MAP2K2 or EC 2.7.12.2) - Pipeline Review, H2 2016

Dual Specificity Mitogen Activated Protein Kinase Kinase 2 (ERK Activator Kinase 2 or MAPK/ERK Kinase 2 or MAP2K2 or EC 2.7.12.2) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Dual Specificity Mitogen Activated Protein Kinase Kinase 2 (ERK Activator Kinase 2 or MAPK/ERK Kinase 2 or MAP2K2 or EC 2.7.12.2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Dual Specificity ...

  • Industries : Therapy
Dual Specificity Mitogen Activated Protein Kinase Kinase 1 (ERK Activator Kinase 1 or MAPK/ERK Kinase 1 or MAP2K1 or EC 2.7.12.2) - Pipeline Review, H2 2016

Dual Specificity Mitogen Activated Protein Kinase Kinase 1 (ERK Activator Kinase 1 or MAPK/ERK Kinase 1 or MAP2K1 or EC 2.7.12.2) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Dual Specificity Mitogen Activated Protein Kinase Kinase 1 (ERK Activator Kinase 1 or MAPK/ERK Kinase 1 or MAP2K1 or EC 2.7.12.2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Dual Specificity ...

  • Industries : Therapy
The Market for Needle-Free Drug Delivery Systems

The Market for Needle-Free Drug Delivery Systems

  • $ 3 500
  • Industry report
  • July 2016
  • by Kalorama Information

Kalorama Informaiton's report, The Market for Needle-Free Drug Delivery Systems, details the market for opportunity for needle-free drug systems. Specific data in the report includes: Market Estimate and ...

  • Industries : Drug Delivery, Pharmaceutical, Therapy, Biopharmaceutical
  • Countries : United States, World
Static Compression Therapy Market: India Industry Analysis and Opportunity Assessment, 2015 - 2025

Static Compression Therapy Market: India Industry Analysis and Opportunity Assessment, 2015 - 2025

  • $ 3 500
  • Industry report
  • July 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

Future Market Insights offers a 10-year forecast of the static compression therapy market in India between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 7.2% during the ...

  • Industries : Therapy, Medical Supply
  • Countries : India
Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2016

Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Caspase 3 (Apopain ...

  • Industries : Therapy, Pathology, Biopharmaceutical
  • Countries : United States, World
T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 ...

  • Industries : Biological Therapy, Drug Discovery and Development, Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : World, United States
Tyrosine Protein Kinase Lck (Leukocyte C Terminal Src Kinase or Protein YT16 or Proto Oncogene Lck or T Cell Specific Protein Tyrosine Kinase or Lymphocyte Cell Specific Protein Tyrosine Kinase or p56 LCK or LCK or EC 2.7.10.2) - Pipeline Review, H2 2016

Tyrosine Protein Kinase Lck (Leukocyte C Terminal Src Kinase or Protein YT16 or Proto Oncogene Lck or T Cell Specific Protein Tyrosine Kinase or Lymphocyte Cell Specific Protein Tyrosine Kinase or p56 LCK or LCK or EC 2.7.10.2) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Tyrosine Protein Kinase Lck (Leukocyte C Terminal Src Kinase or Protein YT16 or Proto Oncogene Lck or T Cell Specific Protein Tyrosine Kinase or Lymphocyte Cell Specific Protein Tyrosine Kinase or p56 ...

  • Industries : Therapy, Pathology, Cancer
  • Countries : United States
TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Pipeline Review, H2 2016

TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘TGF Beta Receptor Type 2 (Transforming ...

  • Industries : Drug Discovery and Development
  • Countries : World
Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2016

Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2016’, provides in depth analysis on Toll ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016’, provides in depth analysis on Toll ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : United States, Europe, World
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Granulocyte ...

  • Industries : Biological Therapy, Therapy, Pathology, Biotechnology, Cancer, Pharmaceutical
  • Countries : United States
Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Macrophage Colony ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, World
Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Pipeline Review, H2 2016

Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like ...

  • Industries : Therapy, Biological Therapy, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States
RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) - Pipeline Review, H2 2016

RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Cancer, Pathology
  • Countries : United States
Cyclin-Dependent Kinase 7 (39 kDa Protein Kinase or CDK-Activating Kinase 1 or TFIIH Basal Transcription Factor Complex Kinase Subunit or EC 2.7.11.22) - Pipeline Review, H1 2016

Cyclin-Dependent Kinase 7 (39 kDa Protein Kinase or CDK-Activating Kinase 1 or TFIIH Basal Transcription Factor Complex Kinase Subunit or EC 2.7.11.22) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Cyclin-Dependent Kinase 7 (39 kDa Protein Kinase or CDK-Activating Kinase 1 or TFIIH Basal Transcription Factor Complex Kinase Subunit or EC 2.7.11.22) - Pipeline Review, H1 2016 Summary Global Markets ...

  • Industries : Cancer, Pathology, Therapy, Pharmaceutical
  • Countries : United States
NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2016

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘NT ...

  • Industries : Cancer, Pathology
  • Countries : United States
Smoothened Homolog (Protein Gx or SMO) - Pipeline Review, H1 2016

Smoothened Homolog (Protein Gx or SMO) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Smoothened Homolog (Protein Gx or SMO) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Smoothened Homolog (Protein Gx or SMO) - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Cancer, Therapy, Pathology, Pharmaceutical
  • Countries : United States
Tumor Necrosis Factor Receptor Superfamily Member 1A (Tumor Necrosis Factor Receptor 1 or Tumor Necrosis Factor Receptor Type I or CD120a or TNFRSF1A) - Pipeline Review, H1 2016

Tumor Necrosis Factor Receptor Superfamily Member 1A (Tumor Necrosis Factor Receptor 1 or Tumor Necrosis Factor Receptor Type I or CD120a or TNFRSF1A) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 1A (Tumor Necrosis Factor Receptor 1 or Tumor Necrosis Factor Receptor Type I or CD120a or TNFRSF1A) - Pipeline Review, H1 2016 Summary Global Markets ...

  • Industries : Pathology, Biopharmaceutical
  • Countries : World
Potassium Voltage Gated Channel Subfamily A Member 5 (Voltage Gated Potassium Channel Subunit Kv1.5 or KCNA5) - Pipeline Review, H1 2016

Potassium Voltage Gated Channel Subfamily A Member 5 (Voltage Gated Potassium Channel Subunit Kv1.5 or KCNA5) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Potassium Voltage Gated Channel Subfamily A Member 5 (Voltage Gated Potassium Channel Subunit Kv1.5 or KCNA5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Potassium Voltage Gated Channel ...

  • Industries : Chronic Disease, Pathology, Drug Discovery and Development, Therapy
  • Countries : World, United States, United Kingdom
Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1) - Pipeline Review, H1 2016

Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Aurora ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
CaM Kinase (Ca2+/Calmodulin-Dependent Protein Kinase or EC 2.7.11.17) - Pipeline Review, H1 2016

CaM Kinase (Ca2+/Calmodulin-Dependent Protein Kinase or EC 2.7.11.17) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

CaM Kinase (Ca2+/Calmodulin-Dependent Protein Kinase or EC 2.7.11.17) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘CaM Kinase (Ca2+/Calmodulin-Dependent Protein Kinase or EC 2.7.11.17) ...

  • Industries : Biopharmaceutical, Pathology, Drug Discovery and Development
  • Countries : World, United States, Japan
Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016

Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016 Summary Global Markets ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology, Pharmaceutical, Cancer, Pathology
  • Countries : United States
Leptin Receptor (OB Receptor or CD295 or LEPR) - Pipeline Review, H1 2016

Leptin Receptor (OB Receptor or CD295 or LEPR) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Leptin Receptor (OB Receptor or CD295 or LEPR) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Leptin Receptor (OB Receptor or CD295 or LEPR) - Pipeline Review, H1 2016’, provides in ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Galectin-1 (Gal-1 or Lactose-Binding Lectin 1 or 14 kDa Laminin-Binding Protein) - Pipeline Review, H1 2016

Galectin-1 (Gal-1 or Lactose-Binding Lectin 1 or 14 kDa Laminin-Binding Protein) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Galectin-1 (Gal-1 or Lactose-Binding Lectin 1 or 14 kDa Laminin-Binding Protein) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Galectin-1 (Gal-1 or Lactose-Binding Lectin 1 or 14 kDa ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Cyclin-Dependent Kinase 1 (p34 Protein Kinase or Cell Division Protein Kinase 1 or CDK1 or EC 2.7.11.22) - Pipeline Review, H1 2016

Cyclin-Dependent Kinase 1 (p34 Protein Kinase or Cell Division Protein Kinase 1 or CDK1 or EC 2.7.11.22) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Cyclin-Dependent Kinase 1 (p34 Protein Kinase or Cell Division Protein Kinase 1 or CDK1 or EC 2.7.11.22) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Cyclin-Dependent Kinase 1 (p34 ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : United States
Pol Polyprotein - Pipeline Review, H1 2016

Pol Polyprotein - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Pol Polyprotein - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Pol Polyprotein - Pipeline Review, H1 2016’, provides in depth analysis on Pol Polyprotein targeted pipeline therapeutics. ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology, Pharmaceutical
  • Countries : United States
78 kda Glucose-Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+)-Binding Protein Grp78 or GRP78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain-Binding Protein or BiP or HSPA5) - Pipeline Review, H1 2016

78 kda Glucose-Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+)-Binding Protein Grp78 or GRP78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain-Binding Protein or BiP or HSPA5) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

78 kda Glucose-Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+)-Binding Protein Grp78 or GRP78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain-Binding Protein or BiP or HSPA5) - Pipeline ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States
Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2016

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Macrophage Stimulating ...

  • Industries : Therapy, Cancer, Pathology, Oncology
  • Countries : United States, World
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2016

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Therapy
  • Countries : World, Europe
Dual Specificity Protein Kinase TTK (TTK Protein Kinase or Cancer/Testis Antigen 96 or Monopolar Spindle 1-Like 1 or EC 2.7.12.1) - Pipeline Review, H1 2016

Dual Specificity Protein Kinase TTK (TTK Protein Kinase or Cancer/Testis Antigen 96 or Monopolar Spindle 1-Like 1 or EC 2.7.12.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Dual Specificity Protein Kinase TTK (TTK Protein Kinase or Cancer/Testis Antigen 96 or Monopolar Spindle 1-Like 1 or EC 2.7.12.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Dual Specificity ...

  • Industries : Biopharmaceutical, Cancer
  • Countries : World
About 30 000 reports

Download Unlimited Documents from Trusted Public Sources

Cholesterol Statistics in the US

  • August 2016
    79 pages
  • Cholesterol  

    Cardiovascular ...  

    Therapy  

  • United States  

View report >

Therapy Market

August 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.